Lv2
180 积分 2023-07-20 加入
To B‐ or not to B‐: A review of lineage switched acute leukemia
3个月前
已完结
Global and regional quality of care index in major depressive disorder: the global burden of disease study 2021
6个月前
已完结
Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD–mutated AML
6个月前
已完结
Ex vivo venetoclax sensitivity predicts clinical response in acute myeloid leukemia in the prospective VenEx trial
6个月前
已完结
Venetoclax and decitabine vs intensive chemotherapy as induction for young patients with newly diagnosed AML
6个月前
已完结
Nanobody-based naturally selected CD7-targeted CAR-T therapy for acute myeloid leukemia
6个月前
已完结
CAR-T cell therapy for treatment of acute myeloid leukemia, advances and outcomes
6个月前
已完结
2025 Update on MRD in Acute Myeloid Leukemia: A Consensus Document from the ELN-DAVID MRD Working Party
6个月前
已完结
Refined ELN 2024 risk stratification improves survival prognostication following venetoclax-based therapy in AML
6个月前
已完结
Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendations
6个月前
已完结
皖公网安备34019202002308
